Bank of New York Mellon »

Bridgebio Pharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-03-31 $340k 200k 1.70

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)

View all positions for Bank of New York Mellon

Top funds holding Bridgebio Pharma

Linden Advisors
D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
Jump Financial
CSS
Alberta Investment Management Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Wellington Management Company
Calamos Advisors
Susquehanna Advisors Group
State Street Corporation

View all funds holding Bridgebio Pharma